New sexual dysfunction warnings added to antidepressants’ PI

Health professionals are advised to consider current or previous antidepressant use in patients reporting sexual dysfunction  Updated product information documents (PIs) for nine antidepressant medications will include warnings relating to the risk of persistent sexual dysfunction, the Therapeutic Goods Administration (TGA) reveals.   In an update issued on Thursday (23 May 2024) the regulator said